<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38138892</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Exploring the Influence of <i>VDR</i> Genetic Variants <i>TaqI</i>, <i>ApaI</i>, and <i>FokI</i> on COVID-19 Severity and Long-COVID-19 Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13121663</ELocationID><Abstract><AbstractText>There is increasing evidence regarding the importance of vitamin D in the prognosis of coronavirus disease 2019 (COVID-19). Genetic variants in the vitamin D receptor (<i>VDR</i>) gene affect the response to vitamin D and have been linked to various diseases. This study investigated the associations of the major <i>VDR</i> genetic variants <i>ApaI</i>, <i>FokI</i>, and <i>TaqI</i> with the severity and long post-infection symptoms of COVID-19. In total, 100 Jordanian patients with confirmed COVID-19 were genotyped for the <i>VDR ApaI</i>, <i>FokI</i>, and <i>TaqI</i> variants using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. COVID-19 severity, the most commonly reported long-COVID-19 symptoms that lasted for &gt;4 weeks from the onset of infection, and other variables were analyzed according to <i>VDR</i> genetic variants. In this study, <i>ApaI</i> and <i>FokI</i> polymorphisms showed no significant associations with COVID-19 severity (<i>p</i> &gt; 0.05). However, a significant association was detected between the <i>TaqI</i> polymorphism and the severity of symptoms after infection with the SARS-CoV-2 virus (<i>p</i> = 0.04). The wild-type <i>TaqI</i> genotype was typically present in patients with mild illness, whereas the heterozygous <i>TaqI</i> genotype was present in asymptomatic patients. With regard to long-COVID-19 symptoms, the <i>VDR</i> heterozygous <i>ApaI</i> and wild-type <i>TaqI</i> genotypes were significantly associated with persistent fatigue and muscle pain after COVID-19 (<i>p</i> &#x2c2; 0.05). Most carriers of the heterozygous <i>ApaI</i> genotype and carriers of the wild-type <i>TaqI</i> genotype reported experiencing fatigue and muscle pain that lasted for more than 1 month after the onset of COVID-19. Furthermore, the <i>TaqI</i> genotype was associated with persistent shortness of breath after COVID-19 (<i>p</i> = 0.003). Shortness of breath was more common among individuals with homozygous <i>TaqI</i> genotype than among individuals with the wild-type or heterozygous <i>TaqI</i> genotype. <i>VDR TaqI</i> is a possible genetic variant related to both COVID-19 severity and long-COVID-19 symptoms among Jordanian individuals. The associations between <i>VDR TaqI</i> polymorphisms and long-COVID-19 symptoms should be investigated in larger and more diverse ethnic populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alhammadin</LastName><ForeName>Ghayda'</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0006-6501-5432</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Science, College of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarrar</LastName><ForeName>Yazun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt 19117, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madani</LastName><ForeName>Abdalla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Science, College of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Su-Jun</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-3570-0598</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Pharmacogenomics Research Center, College of Medicine, Inje University, Busan 50834, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2020R1I1A3073778</GrantID><Agency>the National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Jordanians</Keyword><Keyword MajorTopicYN="N">VDR variants</Keyword><Keyword MajorTopicYN="N">long-COVID-19 symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38138892</ArticleId><ArticleId IdType="pmc">PMC10744884</ArticleId><ArticleId IdType="doi">10.3390/jpm13121663</ArticleId><ArticleId IdType="pii">jpm13121663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Y.C., Chen C.S., Chan Y.J. The outbreak of COVID-19: An overview. J. Chin. Med. Assoc. 2020;83:217&#x2013;220. doi: 10.1097/JCMA.0000000000000270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCMA.0000000000000270</ArticleId><ArticleId IdType="pmc">PMC7153464</ArticleId><ArticleId IdType="pubmed">32134861</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. J. Am. Med. Assoc. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K., Thadhani R. Vitamin D Toxicity. Brazilian J. Nephrol. 2020;42:238&#x2013;244. doi: 10.1590/2175-8239-jbn-2019-0192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-jbn-2019-0192</ArticleId><ArticleId IdType="pmc">PMC7427646</ArticleId><ArticleId IdType="pubmed">32255467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Du J., Huang L., Wang Y., Shi Y., Lin H. Preventive effects of Vitamin D on seasonal influenza a in infants: A multicenter, randomized, open, controlled clinical trial. Pediatr. Infect. Dis. J. 2018;37:749&#x2013;754. doi: 10.1097/INF.0000000000001890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001890</ArticleId><ArticleId IdType="pubmed">29315160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber-Bzura B.M. Vitamin D and influenza&#x2014;Prevention or therapy? Int. J. Mol. Sci. 2018;19:2419. doi: 10.3390/ijms19082419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082419</ArticleId><ArticleId IdType="pmc">PMC6121423</ArticleId><ArticleId IdType="pubmed">30115864</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochel N., Moln&#xe1;r F. Structural aspects of vitamin D endocrinology. Mol. Cell. Endocrinol. 2017;453:22&#x2013;35. doi: 10.1016/j.mce.2017.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2017.02.046</ArticleId><ArticleId IdType="pubmed">28257826</ArticleId></ArticleIdList></Reference><Reference><Citation>Alathari B.E., Sabta A.A., Kalpana C.A., Vimaleswaran K.S. Vitamin D pathway-related gene polymorphisms and their association with metabolic diseases: A literature review. J. Dabetes Metab. Disord. 2020;19:1701&#x2013;1729. doi: 10.1007/s40200-020-00561-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40200-020-00561-w</ArticleId><ArticleId IdType="pmc">PMC7843833</ArticleId><ArticleId IdType="pubmed">33553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangin M., Sinha R., Fincher K. Inflammation and vitamin D: The infection connection. Inflamm. Res. 2014;63:803&#x2013;819. doi: 10.1007/s00011-014-0755-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0755-z</ArticleId><ArticleId IdType="pmc">PMC4160567</ArticleId><ArticleId IdType="pubmed">25048990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y., Yao Q., Ma W., Liu H., Ji J., Li X. Associations of Vitamin D deficiency and Vitamin D receptor (Cdx-2, Fok I, Bsm i and Taq I) polymorphisms with the risk of primary open-angle glaucoma. BMC Ophthalmol. 2016;16:116. doi: 10.1186/s12886-016-0289-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-016-0289-y</ArticleId><ArticleId IdType="pmc">PMC4952063</ArticleId><ArticleId IdType="pubmed">27435453</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplana M., Luis Royo J., Fibla J. Vitamin D Receptor Polymorphisms and Risk of Enveloped Virus Infection: A Meta-Analysis. Gene. 2018;678:384&#x2013;394. doi: 10.1016/j.gene.2018.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.08.017</ArticleId><ArticleId IdType="pubmed">30092343</ArticleId></ArticleIdList></Reference><Reference><Citation>Makoui M.H., Imani D., Motallebnezhad M., Azimi M., Razi B. Vitamin D receptor gene polymorphism and susceptibility to asthma: Meta-analysis based on 17 case-control studies. Ann. Allergy Asthma Immunol. 2020;124:57&#x2013;69. doi: 10.1016/j.anai.2019.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2019.10.014</ArticleId><ArticleId IdType="pubmed">31654764</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi A., Khanbabaei H., Nasiri-Kalmarzi R., Khademi F., Jafari M., Tajik N. Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian population: A systematic review and meta-analysis. J. Microbiol. Immunol. Infect. 2019;53:827&#x2013;835. doi: 10.1016/j.jmii.2019.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2019.08.011</ArticleId><ArticleId IdType="pubmed">31740220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhang S., He C., Wang X. VDR Gene Polymorphisms and Allergic Diseases: Evidence from a Meta-analysis. Immunol. Investig. 2019;49:166&#x2013;177. doi: 10.1080/08820139.2019.1674325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2019.1674325</ArticleId><ArticleId IdType="pubmed">31752548</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L., Bhattoa H.P. Evidence that vitamin d supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12040988</ArticleId><ArticleId IdType="pmc">PMC7231123</ArticleId><ArticleId IdType="pubmed">32252338</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdollahzadeh R., Shushizadeh M.H., Barazandehrokh M., Choopani S., Azarnezhad A., Paknahad S., Pirhoushiaran M., Makani S.Z., Yeganeh R.Z., Al-Kateb A., et al. Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients. Infect. Genet. Evol. 2021;96:105098. doi: 10.1016/j.meegid.2021.105098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105098</ArticleId><ArticleId IdType="pmc">PMC8487094</ArticleId><ArticleId IdType="pubmed">34610433</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaydin T., Polat H., Dincer Yazan C., Ilgin C., Elbasan O., Dashdamirova S., Bayram F., Tukenmez Tigen E., Unlu O., Tekin A.F., et al. Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19. Clin. Endocrinol. 2022;96:819&#x2013;830. doi: 10.1111/cen.14664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14664</ArticleId><ArticleId IdType="pubmed">34919268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Jafar T., Mahdi F., Ameta K., Arshad M., Das S.K., Waliullah S., Rizvi I., Mahdi A.A. Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women. Gene. 2018;659:123&#x2013;127. doi: 10.1016/j.gene.2018.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.03.052</ArticleId><ArticleId IdType="pubmed">29559350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjbar M., Whetstone C.E., Omer H., Power L., Cusack R.P., Gauvreau G.M. The Genetic Factors of the Airway Epithelium Associated with the Pathology of Asthma. Genes. 2022;13:1870. doi: 10.3390/genes13101870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13101870</ArticleId><ArticleId IdType="pmc">PMC9601469</ArticleId><ArticleId IdType="pubmed">36292755</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhawari H., Jarrar Y., Abulebdah D., Abaalkhail S.J., Alkhalili M., Alkhalili S., Alhawari H., Momani M., Obeidat M.N., Fram R.K., et al. Effects of Vitamin D Receptor Genotype on Lipid Profiles and Retinopathy Risk in Type 2 Diabetes Patients: A Pilot Study. J. Pers. Med. 2022;12:1488. doi: 10.3390/jpm12091488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12091488</ArticleId><ArticleId IdType="pmc">PMC9505147</ArticleId><ArticleId IdType="pubmed">36143273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall F.Q. Body mass index: Obesity, BMI, and health: A critical review. Nutr. Today. 2015;50:117&#x2013;128. doi: 10.1097/NT.0000000000000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NT.0000000000000092</ArticleId><ArticleId IdType="pmc">PMC4890841</ArticleId><ArticleId IdType="pubmed">27340299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleasants R.A., Rivera M.P., Tilley S.L., Bhatt S.P. Both Duration and Pack-Years of Tobacco Smoking Should Be Used for Clinical Practice and Research. Ann. Am. Thorac. Soc. 2020;17:804&#x2013;806. doi: 10.1513/AnnalsATS.202002-133VP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202002-133VP</ArticleId><ArticleId IdType="pmc">PMC7405110</ArticleId><ArticleId IdType="pubmed">32348693</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health.  [(accessed on 15 April 2023)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>World Health Organization.  [(accessed on 15 April 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) Indian J. Pediatr. 2020;87:281&#x2013;286. doi: 10.1007/s12098-020-03263-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-020-03263-6</ArticleId><ArticleId IdType="pmc">PMC7090728</ArticleId><ArticleId IdType="pubmed">32166607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildirim Z., Sahin O.S., Yazar S., Bozok Cetintas V. Genetic and epigenetic factors associated with increased severity of COVID-19. Cell Biol. Int. 2021;45:1158&#x2013;1174. doi: 10.1002/cbin.11572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11572</ArticleId><ArticleId IdType="pmc">PMC8014716</ArticleId><ArticleId IdType="pubmed">33590936</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Gkizarioti Z., Patrinos G.P., Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum. Genomics. 2020;14:40. doi: 10.1186/s40246-020-00290-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00290-4</ArticleId><ArticleId IdType="pmc">PMC7578581</ArticleId><ArticleId IdType="pubmed">33092637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus D., Degenhardt F., Bujanda L., Buti M., Albillos A., Invernizzi P., Fern&#xe1;ndez J., Prati D., Baselli G., Asselta R., et al. The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis. medRxiv. 2020 preprint .</Citation></Reference><Reference><Citation>Kaltoum A.B.O. Mutations and polymorphisms in genes involved in the infections by COVID 19: A review. Gene Rep. 2021;23:101062. doi: 10.1016/j.genrep.2021.101062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101062</ArticleId><ArticleId IdType="pmc">PMC7906531</ArticleId><ArticleId IdType="pubmed">33655087</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khateeb M., Khader Y., Batieha A., Jaddou H., Hyassat D., Khawaja N., Abujbara M., Ajlouni K. Vitamin D deficiency and associated factors in Jordan. SAGE Open Med. 2019;7:1&#x2013;6. doi: 10.1177/2050312119876151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312119876151</ArticleId><ArticleId IdType="pmc">PMC8826271</ArticleId><ArticleId IdType="pubmed">35154754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike J.W., Meyer M.B., Lee S.M., Onal M., Benkusky N.A. The Vitamin D receptor: Contemporary genomic approaches reveal new basic and translational insights. J. Clin. Investig. 2017;127:1146&#x2013;1154. doi: 10.1172/JCI88887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI88887</ArticleId><ArticleId IdType="pmc">PMC5373853</ArticleId><ArticleId IdType="pubmed">28240603</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccone D., Asani F., Bornman L. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene. 2015;561:171&#x2013;180. doi: 10.1016/j.gene.2015.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.02.024</ArticleId><ArticleId IdType="pubmed">25682935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Xu Y., Sun C., Wang X., Guo Y., Qiu S., Ma K. A systematic review of asymptomatic infections with COVID-19. J. Microbiol. Immunol. Infect. 2021;54:12&#x2013;16. doi: 10.1016/j.jmii.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227597</ArticleId><ArticleId IdType="pubmed">32425996</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Harbi M., Al Kaabi N., Al Nuaimi A., Abdalla J., Khan T., Gasmelseed H., Khan A., Hamdoun O., Weber S. Clinical and laboratory characteristics of patients hospitalised with COVID-19: Clinical outcomes in Abu Dhabi, United Arab Emirates. BMC Infect. Dis. 2022;22:136. doi: 10.1186/s12879-022-07059-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07059-1</ArticleId><ArticleId IdType="pmc">PMC8822868</ArticleId><ArticleId IdType="pubmed">35135491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Mohammadi N., Breyman E., Nasr L., et al. Post-acute COVID-19 syndrome negatively impacts health and wellbeing despite less severe acute infection. medRxiv. 2020:preprint.</Citation></Reference><Reference><Citation>Galal I., Hussein A.A., Amin M.T., Saad M.M., Zayan H.E., Abdelsayed M.Z., Moustafa M.M., Ezzat A.R., Helmy R.E., Abd_Elaal H.K., et al. Determinants of persistent post-COVID-19 symptoms: Value of a novel COVID-19 symptom score. Egypt. J. Bronchol. 2021;15:10. doi: 10.1186/s43168-020-00049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:1494. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Khdair S.I., Jarrar Y.B., Jarrar W. Immunogenetic Prediction of VDR Gene SNPs: Lack of Association with Susceptibility to Type 1 Diabetes in Jordanian Patients. Diabetes Metab. Syndr. Obes. 2021;14:4079&#x2013;4087. doi: 10.2147/DMSO.S333005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S333005</ArticleId><ArticleId IdType="pmc">PMC8464324</ArticleId><ArticleId IdType="pubmed">34584434</ArticleId></ArticleIdList></Reference><Reference><Citation>Peralta E.M., Rosales Y.Z., Mesa T.C., Gonz&#xe1;lez E.N., P&#xe9;rez Y.H., de los &#xc1;ngeles Gonz&#xe1;lez Torres M., Balbuena H.R., Teruel B.M. TaqI polymorphism of the VDR gene: Aspects related to the clinical behavior of COVID-19 in Cuban patients. Egypt. J. Med. Hum. Genet. 2021;22:1&#x2013;4. doi: 10.1186/s43042-021-00206-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43042-021-00206-4</ArticleId><ArticleId IdType="pmc">PMC8629595</ArticleId><ArticleId IdType="pubmed">38624931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotur N., Skakic A., Klaassen K., Gasic V., Zukic B. Association of Vitamin D, Zinc and Selenium Related Genetic Variants with COVID-19 Disease Severity. Front. Nutr. 2021;8:689419. doi: 10.3389/fnut.2021.689419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.689419</ArticleId><ArticleId IdType="pmc">PMC8211741</ArticleId><ArticleId IdType="pubmed">34150833</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers S.K., Lynch G.S., Murphy K.T., Reid M.B., Zijdewind I. Disease-Induced Skeletal Muscle Atrophy and Fatigue Scott. Med. Sci. Sports Exerc. 2016;48:2307&#x2013;2319. doi: 10.1249/MSS.0000000000000975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000000975</ArticleId><ArticleId IdType="pmc">PMC5069191</ArticleId><ArticleId IdType="pubmed">27128663</ArticleId></ArticleIdList></Reference><Reference><Citation>Massidda M., Corrias L., Bachis V., Cugia P., Piras F., Scorcu M., Cal&#xf2; C.M. Vitamin D receptor gene polymorphisms and musculoskeletal injuries in professional football players. Exp. Ther. Med. 2015;9:1974&#x2013;1978. doi: 10.3892/etm.2015.2364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2015.2364</ArticleId><ArticleId IdType="pmc">PMC4489103</ArticleId><ArticleId IdType="pubmed">26161149</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos S.K., Fernandes K.B., Zicarelli C.A., Santana A.V., Perrucini P.D., Poli-Frederico R.C. Poli-Frederico. Evaluation of ApaI and FokI polymorphism of VDR gene and functional characterization in patients with fibromyalgia. Fisioter. Mov. 2022;35:e35122. doi: 10.1590/fm.2022.35122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/fm.2022.35122</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrumpf J.A., Amatngalim G.D., Veldkamp J.B., Verhoosel R.M., Ninaber D.K., Ordonez S.R., van der Does A.M., Haagsman H.P., Hiemstra P.S. Proinflammatory cytokines impair Vitamin D-induced host defense in cultured airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2017;56:749&#x2013;761. doi: 10.1165/rcmb.2016-0289OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2016-0289OC</ArticleId><ArticleId IdType="pubmed">28231019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.E.A., Hassan M.H., Toghan R., Rashwan N.I. Analysis of 25-hydroxy cholecalciferol, immunoglobulin E, and vitamin D receptor single nucleotide polymorphisms (Apa1, Taq1, and Bsm1), among sample of Egyptian children with bronchial asthma: A case-control study. Pediatr. Pulmonol. 2020;55:1349&#x2013;1358. doi: 10.1002/ppul.24785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24785</ArticleId><ArticleId IdType="pubmed">32311846</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou A., Kouis P., Middleton N., Kolokotroni O., Karpathios T., Nicolaidou P., Yiallouros P.K. Association of vitamin D receptor gene polymorphisms and vitamin D levels with asthma and atopy in Cypriot adolescents: A case-control study. Multidiscip. Respir. Med. 2015;10:26. doi: 10.1186/s40248-015-0025-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40248-015-0025-0</ArticleId><ArticleId IdType="pmc">PMC4559891</ArticleId><ArticleId IdType="pubmed">26346690</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>